Literature DB >> 19541924

Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet.

Sean W P Koppe1, Marc Elias, Richard H Moseley, Richard M Green.   

Abstract

Diets high in trans fats are associated with an increased risk of cardiovascular disease and components of the metabolic syndrome. The influence of these toxic fatty acids on the development of nonalcoholic fatty liver disease has not been significantly examined. Therefore, we sought to compare the effect of a murine diet high in trans fat to a standard high-fat diet that is devoid of trans fats but high in saturated fats. Male AKR/J mice were fed a calorically identical trans fat diet or standard high-fat diet for 10 days, 4 wk, and 8 wk. Serum alanine aminotransferase (ALT), lipid, insulin, and leptin levels were determined and the quantitative insulin-sensitivity check index (QUICKI) was calculated as a measure of insulin resistance. Additionally, hepatic triglyceride content and gene expression of several proinflammatory genes were assessed. By 8 wk, trans fat-fed mice exhibited higher ALT values than standard high-fat-fed mice (126 +/- 16 vs. 71 +/- 7 U/l, P < 0.02) despite similar hepatic triglyceride content at each time point. Trans fat-fed mice also had increased insulin resistance compared with high-fat-fed mice at 4 and 8 wk with significantly higher insulin levels and lower QUICKI values. Additionally, hepatic interleukin-1beta (IL-1beta) gene expression was 3.6-fold higher at 4 wk (P < 0.05) and 5-fold higher at 8 wk (P < 0.05) in trans fat-fed mice compared with standard high-fat-fed mice. Trans fat feeding results in higher ALT values, increased insulin resistance, and elevated IL-1beta levels compared with standard high-fat feeding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541924      PMCID: PMC2724085          DOI: 10.1152/ajpgi.90543.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  52 in total

1.  Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM.

Authors:  E Christiansen; S Schnider; B Palmvig; E Tauber-Lassen; O Pedersen
Journal:  Diabetes Care       Date:  1997-05       Impact factor: 19.112

2.  A high-trans fatty acid diet and insulin sensitivity in young healthy women.

Authors:  A M Louheranta; A K Turpeinen; H M Vidgren; U S Schwab; M I Uusitupa
Journal:  Metabolism       Date:  1999-07       Impact factor: 8.694

3.  Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction.

Authors:  Esther Lopez-Garcia; Matthias B Schulze; James B Meigs; JoAnn E Manson; Nader Rifai; Meir J Stampfer; Walter C Willett; Frank B Hu
Journal:  J Nutr       Date:  2005-03       Impact factor: 4.798

4.  Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study.

Authors:  Kyungwon Oh; Frank B Hu; JoAnn E Manson; Meir J Stampfer; Walter C Willett
Journal:  Am J Epidemiol       Date:  2005-04-01       Impact factor: 4.897

5.  Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse.

Authors:  Kohjiro Ueki; Tatsuya Kondo; Yu-Hua Tseng; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

6.  Estimated intakes of trans fatty and other fatty acids in the US population.

Authors:  D B Allison; S K Egan; L M Barraj; C Caughman; M Infante; J T Heimbach
Journal:  J Am Diet Assoc       Date:  1999-02

7.  The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia.

Authors:  Nadine S Sauter; Fabienne T Schulthess; Ryan Galasso; Lawrence W Castellani; Kathrin Maedler
Journal:  Endocrinology       Date:  2008-01-31       Impact factor: 4.736

8.  Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States.

Authors:  A Ascherio; E B Rimm; E L Giovannucci; D Spiegelman; M Stampfer; W C Willett
Journal:  BMJ       Date:  1996-07-13

9.  Differential effects of cis and trans fatty acids on insulin release from isolated mouse islets.

Authors:  K K Alstrup; S Gregersen; H M Jensen; J L Thomsen; K Hermansen
Journal:  Metabolism       Date:  1999-01       Impact factor: 8.694

10.  Transient increase in obese gene expression after food intake or insulin administration.

Authors:  R Saladin; P De Vos; M Guerre-Millo; A Leturque; J Girard; B Staels; J Auwerx
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

View more
  18 in total

Review 1.  Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease.

Authors:  Rebecca C Schugar; Peter A Crawford
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-07       Impact factor: 4.294

2.  Effect of a trans fatty acid-enriched diet on biochemical and inflammatory parameters in Wistar rats.

Authors:  Rafael Longhi; Roberto Farina Almeida; Letiane Machado; Maria Marta Medeiros Frescura Duarte; Débora Guerini Souza; Priscila Machado; Adriano Martimbianco de Assis; André Quincozes-Santos; Diogo Onofre Souza
Journal:  Eur J Nutr       Date:  2016-01-11       Impact factor: 5.614

Review 3.  New insights from rodent models of fatty liver disease.

Authors:  Jacquelyn J Maher
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

4.  Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet.

Authors:  Joel R Garbow; Jason M Doherty; Rebecca C Schugar; Sarah Travers; Mary L Weber; Anna E Wentz; Nkiruka Ezenwajiaku; David G Cotter; Elizabeth M Brunt; Peter A Crawford
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-31       Impact factor: 4.052

Review 5.  Implications of diet on nonalcoholic fatty liver disease.

Authors:  Shelby Sullivan
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

Review 6.  Trans-fatty acids and nonlipid risk factors.

Authors:  Sarah K Wallace; Dariush Mozaffarian
Journal:  Curr Atheroscler Rep       Date:  2009-11       Impact factor: 5.113

7.  Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools.

Authors:  Brent A Neuschwander-Tetri; David A Ford; Sahaja Acharya; George Gilkey; Metin Basaranoglu; Laura H Tetri; Elizabeth M Brunt
Journal:  Lipids       Date:  2012-08-26       Impact factor: 1.880

8.  Diet Significantly Influences the Immunopathology and Severity of Kidney Injury in Male C57Bl/6J Mice in a Model Dependent Manner.

Authors:  John E Brus; Daniel L Quan; Kristin J Wiley; Brittney Browning; Hannah Ter Haar; Riley Lutz; Jeffrey F Houghton; Joseph C Gigliotti
Journal:  Nutrients       Date:  2021-04-30       Impact factor: 5.717

9.  Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal women.

Authors:  N T Bendsen; E Chabanova; H S Thomsen; T M Larsen; J W Newman; S Stender; J Dyerberg; S B Haugaard; A Astrup
Journal:  Nutr Diabetes       Date:  2011-01-31       Impact factor: 5.097

10.  Loss of 5α-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice.

Authors:  Joanna K Dowman; Laurence J Hopkins; Gary M Reynolds; Matthew J Armstrong; Maryam Nasiri; Nikolaos Nikolaou; E Leonie A F van Houten; Jenny A Visser; Stuart A Morgan; Gareth G Lavery; Andrei Oprescu; Stefan G Hübscher; Philip N Newsome; Jeremy W Tomlinson
Journal:  Endocrinology       Date:  2013-09-30       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.